跳至主要内容
临床试验/RPCEC00000301
RPCEC00000301尚未招募2 期

Diagnostic efficacy of the nasal provocation test in patients with allergic rhinitis sensitive to house dust mites.

ational Center of Bioproducts (BioCen)0 个研究点目标入组 300 人开始时间: 2019年4月15日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Diagnostic

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Allergic group (Group A):
  • 1) Patients with a positive clinical history of persistent allergic rhinitis to home dust, according to the diagnostic criteria.
  • 2) Age between 18 and 50 years.
  • 3) Patients with a skin prick test with allergen extracts investigated (VALERGEN-DP, VALERGEN-DS and VALERGEN-BT 20 000 UB/ mL), negative (diameter of wheal <3 mm).
  • 4) People of any sex who express their informed consent in writing to participate in the study.
  • 5) Negative nasal discharge.
  • 6) Physical Examination of anterior nostril negative for allergic rhinitis.
  • - Non-allergic group (Group B):
  • 1) Non-allergic subjects without a positive clinical history of persistent allergic rhinitis to house dust, according to the diagnostic criteria described.
  • 2) Age between 18 and 50 years.
  • 3) Non-allergic individuals with a skin prick test with allergen extracts investigated (VALERGEN-DP, VALERGEN-DS and VALERGEN-BT at 20,000 UB/mL), negative (wheal diameter <3 mm).
  • 4) People of any sex who express their informed consent in writing to participate in the study.
  • 5) Negative nasal discharge.
  • 6) Physical Examination of anterior nostril negative for allergic rhinitis.

排除标准

  • 1) Patients treated by Immunotherapy with allergenic extracts of D. pteronyssinus, D. siboney, D. farinae, B. tropical or home dust in the last two years.
  • 2) Patients with symptoms of asthma, otitis media with effusion, acute sinusitis, rhinitis or conjunctivitis at the time of the tests.
  • 3) Current use of drugs that interfere with the cutaneous and nasal reaction of the tests to be performed, which must be previously suspended.
  • 4) Dermographism, atopic dermatitis in the area of skin test and urticaria.
  • 5) Patients who do not express their written consent to participate in the study.

研究者

发起方
ational Center of Bioproducts (BioCen)

相似试验